Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008387944> ?p ?o ?g. }
- W2008387944 endingPage "S22" @default.
- W2008387944 startingPage "S14" @default.
- W2008387944 abstract "The first of the so-called “novel agents” (thalidomide, lenalidomide, and bortezomib), thalidomide has demonstrated activity as a single agent and in combination with other agents in patients with relapsed and/or refractory MM. The combination of melphalan, prednisone, and thalidomide (MPT) has become a standard treatment option for newly diagnosed patients who are ineligible for high-dose chemotherapy with autologous stem cell transplantation (ASCT). For patients intending to undergo ASCT, the combination of thalidomide, dexamethasone and cyclophosphamide can be used as a non-myelosuppressive induction regimen. Treatment with thalidomide is associated with an increased risk of developing peripheral neuropathy, which can be managed with dose reductions and discontinuation, and venous thromboembolism, which warrants thromboprophylaxis. While its adverse event profile may preclude prolonged use as maintenance therapy, thalidomide is an effective and well-tolerated salvage therapy option. Ongoing trials continue to evaluate novel thalidomide-based regimens to further optimize the use of thalidomide in the management of MM." @default.
- W2008387944 created "2016-06-24" @default.
- W2008387944 creator A5016246851 @default.
- W2008387944 creator A5034560778 @default.
- W2008387944 date "2013-10-01" @default.
- W2008387944 modified "2023-09-25" @default.
- W2008387944 title "Role of thalidomide in the treatment of patients with multiple myeloma" @default.
- W2008387944 cites W1556628912 @default.
- W2008387944 cites W1587685635 @default.
- W2008387944 cites W1597238753 @default.
- W2008387944 cites W1847244426 @default.
- W2008387944 cites W1906348670 @default.
- W2008387944 cites W1963909872 @default.
- W2008387944 cites W1964419796 @default.
- W2008387944 cites W1964981758 @default.
- W2008387944 cites W1975783065 @default.
- W2008387944 cites W1977949460 @default.
- W2008387944 cites W1985147506 @default.
- W2008387944 cites W1987068734 @default.
- W2008387944 cites W1991466811 @default.
- W2008387944 cites W1994721812 @default.
- W2008387944 cites W1998723844 @default.
- W2008387944 cites W2020778579 @default.
- W2008387944 cites W2024363681 @default.
- W2008387944 cites W2026448323 @default.
- W2008387944 cites W2028399237 @default.
- W2008387944 cites W2036200625 @default.
- W2008387944 cites W2038288119 @default.
- W2008387944 cites W2038886835 @default.
- W2008387944 cites W2039496823 @default.
- W2008387944 cites W2039716417 @default.
- W2008387944 cites W2040903318 @default.
- W2008387944 cites W2055338149 @default.
- W2008387944 cites W2059857442 @default.
- W2008387944 cites W2059873406 @default.
- W2008387944 cites W2061807782 @default.
- W2008387944 cites W2072753134 @default.
- W2008387944 cites W2074734350 @default.
- W2008387944 cites W2074981639 @default.
- W2008387944 cites W2082741854 @default.
- W2008387944 cites W2083480184 @default.
- W2008387944 cites W2085092835 @default.
- W2008387944 cites W2093757149 @default.
- W2008387944 cites W2096207943 @default.
- W2008387944 cites W2101576302 @default.
- W2008387944 cites W2102591890 @default.
- W2008387944 cites W2107252423 @default.
- W2008387944 cites W2110466835 @default.
- W2008387944 cites W2111039305 @default.
- W2008387944 cites W2113020324 @default.
- W2008387944 cites W2114217833 @default.
- W2008387944 cites W2119810076 @default.
- W2008387944 cites W2120780398 @default.
- W2008387944 cites W2121399230 @default.
- W2008387944 cites W2125169598 @default.
- W2008387944 cites W2125559109 @default.
- W2008387944 cites W2125721471 @default.
- W2008387944 cites W2128084036 @default.
- W2008387944 cites W2133986577 @default.
- W2008387944 cites W2136373453 @default.
- W2008387944 cites W2138095669 @default.
- W2008387944 cites W2143860449 @default.
- W2008387944 cites W2148188974 @default.
- W2008387944 cites W2151989390 @default.
- W2008387944 cites W2162559503 @default.
- W2008387944 cites W2164669124 @default.
- W2008387944 cites W2316160054 @default.
- W2008387944 cites W3145716452 @default.
- W2008387944 cites W4211136726 @default.
- W2008387944 doi "https://doi.org/10.1016/j.critrevonc.2013.05.012" @default.
- W2008387944 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23827438" @default.
- W2008387944 hasPublicationYear "2013" @default.
- W2008387944 type Work @default.
- W2008387944 sameAs 2008387944 @default.
- W2008387944 citedByCount "18" @default.
- W2008387944 countsByYear W20083879442013 @default.
- W2008387944 countsByYear W20083879442014 @default.
- W2008387944 countsByYear W20083879442015 @default.
- W2008387944 countsByYear W20083879442016 @default.
- W2008387944 countsByYear W20083879442019 @default.
- W2008387944 countsByYear W20083879442020 @default.
- W2008387944 countsByYear W20083879442021 @default.
- W2008387944 countsByYear W20083879442022 @default.
- W2008387944 crossrefType "journal-article" @default.
- W2008387944 hasAuthorship W2008387944A5016246851 @default.
- W2008387944 hasAuthorship W2008387944A5034560778 @default.
- W2008387944 hasConcept C126322002 @default.
- W2008387944 hasConcept C141071460 @default.
- W2008387944 hasConcept C143998085 @default.
- W2008387944 hasConcept C197934379 @default.
- W2008387944 hasConcept C2776063141 @default.
- W2008387944 hasConcept C2776364478 @default.
- W2008387944 hasConcept C2776694085 @default.
- W2008387944 hasConcept C2776755627 @default.
- W2008387944 hasConcept C2777478702 @default.
- W2008387944 hasConcept C2778684742 @default.
- W2008387944 hasConcept C2778715236 @default.
- W2008387944 hasConcept C2778720950 @default.